ESAB trades near the bottom of its fifty-two-week range, roughly forty-four percent below the high, after a year in which organic demand stayed flat, two large deals closed in eight months, and the balance sheet took on a fresh layer of senior claims. The filings describe a company that bought most of its reported growth and is still paying for it. The stock has been repriced from a premium roll up to a discounted one, and that repricing sits in tension with the second quarter results, which show core adjusted EBITDA growing at a moderate rate while margins compress.
The recent annual and quarterly filings describe a company that closed two large acquisitions in eight months. The Eddyfi deal was funded with 1 billion of senior notes, a bridge loan, and a common stock placement. Core adjusted EBITDA was 285.5 million. The rate of increase was a mid single digit percentage. Core sales reached 1,480.8 million in the same window. The Americas posted a 19.9 percent core margin. EMEA & APAC posted 18.8 percent. The gap between the filings and the multiple is the whole story. The stock trades at a single digit multiple of reported adjusted EBITDA. The market capitalization is near 4.7 billion. That is a low for the last two years. Enterprise value of roughly 7.2 billion sits near 12.9 times that same figure. The bear case is that EWM and Eddyfi dilute margins for several quarters, leverage sits at or near covenant headroom, and organic demand never restarts. The bull case is that consumables repricing protects the margin line, EWM brings accretion, and Eddyfi converts a welding consumables house into an inspection and monitoring platform.